Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: BIOCAUSE HEILEN PHARMA(301211) the Revenue is 127.35 M (+5.84%);the EBIT is 14.11 M (+1367%);the EPS is 0.0523 (+231.9%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.13B5.84%
----
----
EBIT
0.01B1366.99%
----
----
EPS
0.0523231.86%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf